Exposure to cigarette smoke disturbs adipokines secretion causing intercellular damage and insulin resistance in high fructose diet-induced metabolic disorder mice

Biochemical and Biophysical Research Communications
Sanghwa KimMyung-Haing Cho

Abstract

A large amount of fructose intake along with smoking is associated with increased incidence of diseases linked to metabolic syndrome. More research is necessary to understand the complex mechanism that ultimately results in metabolic syndrome and the effect, if any, of high fructose dietary intake and smoking on individual health. In this study, we investigated changes in ER-Golgi network and disturbance to secretion of adipokines induced by cigarette smoking (CS) and excess fructose intake and their contribution to the disruption of metabolic homeostasis. We used high fructose-induced metabolic disorder mice model by feeding them with high fructose diet for 8 weeks. For CS exposure experiment, these mice were exposed to CS for 28 days according to OECD guideline 412. Our results clearly showed that the immune system was suppressed and ER stress was induced in mice with exposure to CS and fed with high fructose. Furthermore, their concentrations of adipokines including leptin and adiponectin were aberrant. Such alteration in secretion of adipokines could cause insulin resistance which may lead to the development of type 2 diabetes.

References

May 9, 1992·Lancet·F S FacchiniG M Reaven
Mar 27, 1999·European Journal of Clinical Investigation·B Eliasson, U Smith
May 18, 2004·Endocrine·Stephen E Borst
Jan 28, 2005·Respiratory Medicine·R BroekhuizenE F M Wouters
Jun 21, 2005·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Janne E ReselandChristian A Drevon
Dec 7, 2007·The Journal of Clinical Investigation·Tsuguhito OtaHenry N Ginsberg
Jan 9, 2008·Biochimica Et Biophysica Acta·Linglin XieSilvia Mora
Apr 11, 2008·The American Journal of Clinical Nutrition·Arnaud ChioleroJacques Cornuz
Jun 21, 2008·American Journal of Hypertension·Mor Oron-HermanYehonatan Sharabi
Aug 30, 2008·Molecular Pharmacology·Toru HosoiKoichiro Ozawa
Oct 29, 2008·Seminars in Liver Disease·Onpan Cheung, Arun J Sanyal
Nov 15, 2008·Molecular Medicine·Katja RabeUli C Broedl
Feb 13, 2010·Annual Review of Physiology·Jerrold M Olefsky, Christopher K Glass
Jun 19, 2010·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·L XuM Niessen
Sep 4, 2010·Circulation Research·Sarah Hummasti, Gökhan S Hotamisligil
Sep 6, 2011·Trends in Molecular Medicine·Miriam CnopLicio A Velloso
Jan 18, 2012·Annual Review of Medicine·Lale Ozcan, Ira Tabas
Feb 2, 2012·The Journal of Toxicological Sciences·Koichi TomodaHiroshi Kimura
May 17, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Petros YpsilantisConstantinos Simopoulos
Feb 23, 2013·Genes & Development·Wei ZhangStephen M Cohen
Feb 13, 2016·Tobacco Induced Diseases·Maria KryftiKonstantinos I Gourgoulianis
Sep 10, 2016·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Kyeong-Nam YuMyung-Haing Cho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.